Peringatan Keamanan

Symptoms of overdose include anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region, skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD50=262 mg/kg (I.P. in rat).

Rolitetracycline

DB01301

small molecule approved

Deskripsi

A pyrrolidinylmethyl tetracycline.

Struktur Molekul 2D

Berat 527.5662
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Makanan

1 Data
  • 1. Avoid milk and dairy products. Dairy products contain cations such as calcium which may interfere with the absorption of rolitetracycline.

Interaksi Obat

283 Data
Succinylcholine The therapeutic efficacy of Succinylcholine can be increased when used in combination with Rolitetracycline.
Metocurine iodide The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Rolitetracycline.
Gallamine triethiodide The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Rolitetracycline.
Cisatracurium Rolitetracycline may increase the neuromuscular blocking activities of Cisatracurium.
Rocuronium The therapeutic efficacy of Rocuronium can be increased when used in combination with Rolitetracycline.
Atracurium besylate The therapeutic efficacy of Atracurium besylate can be increased when used in combination with Rolitetracycline.
Doxacurium The therapeutic efficacy of Doxacurium can be increased when used in combination with Rolitetracycline.
Mivacurium The therapeutic efficacy of Mivacurium can be increased when used in combination with Rolitetracycline.
Decamethonium The therapeutic efficacy of Decamethonium can be increased when used in combination with Rolitetracycline.
Metocurine The therapeutic efficacy of Metocurine can be increased when used in combination with Rolitetracycline.
Pancuronium The therapeutic efficacy of Pancuronium can be increased when used in combination with Rolitetracycline.
Pipecuronium The therapeutic efficacy of Pipecuronium can be increased when used in combination with Rolitetracycline.
Vecuronium The therapeutic efficacy of Vecuronium can be increased when used in combination with Rolitetracycline.
Rapacuronium The therapeutic efficacy of Rapacuronium can be increased when used in combination with Rolitetracycline.
Pyrantel The therapeutic efficacy of Pyrantel can be increased when used in combination with Rolitetracycline.
Neosaxitoxin The therapeutic efficacy of Neosaxitoxin can be increased when used in combination with Rolitetracycline.
Atracurium The therapeutic efficacy of Atracurium can be increased when used in combination with Rolitetracycline.
Gallamine The therapeutic efficacy of Gallamine can be increased when used in combination with Rolitetracycline.
Alcuronium The therapeutic efficacy of Alcuronium can be increased when used in combination with Rolitetracycline.
Tubocurarine The therapeutic efficacy of Tubocurarine can be increased when used in combination with Rolitetracycline.
Mecamylamine Rolitetracycline may increase the neuromuscular blocking activities of Mecamylamine.
Mipomersen Rolitetracycline may increase the hepatotoxic activities of Mipomersen.
Flucloxacillin The therapeutic efficacy of Flucloxacillin can be decreased when used in combination with Rolitetracycline.
Piperacillin The therapeutic efficacy of Piperacillin can be decreased when used in combination with Rolitetracycline.
Ampicillin The therapeutic efficacy of Ampicillin can be decreased when used in combination with Rolitetracycline.
Phenoxymethylpenicillin The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Rolitetracycline.
Dicloxacillin The therapeutic efficacy of Dicloxacillin can be decreased when used in combination with Rolitetracycline.
Carbenicillin The therapeutic efficacy of Carbenicillin can be decreased when used in combination with Rolitetracycline.
Nafcillin The therapeutic efficacy of Nafcillin can be decreased when used in combination with Rolitetracycline.
Oxacillin The therapeutic efficacy of Oxacillin can be decreased when used in combination with Rolitetracycline.
Hetacillin The therapeutic efficacy of Hetacillin can be decreased when used in combination with Rolitetracycline.
Benzylpenicilloyl polylysine The therapeutic efficacy of Benzylpenicilloyl polylysine can be decreased when used in combination with Rolitetracycline.
Mezlocillin The therapeutic efficacy of Mezlocillin can be decreased when used in combination with Rolitetracycline.
Cyclacillin The therapeutic efficacy of Cyclacillin can be decreased when used in combination with Rolitetracycline.
Benzylpenicillin The therapeutic efficacy of Benzylpenicillin can be decreased when used in combination with Rolitetracycline.
Amoxicillin The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Rolitetracycline.
Azlocillin The therapeutic efficacy of Azlocillin can be decreased when used in combination with Rolitetracycline.
Cloxacillin The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Rolitetracycline.
Amdinocillin The therapeutic efficacy of Amdinocillin can be decreased when used in combination with Rolitetracycline.
Bacampicillin The therapeutic efficacy of Bacampicillin can be decreased when used in combination with Rolitetracycline.
Meticillin The therapeutic efficacy of Meticillin can be decreased when used in combination with Rolitetracycline.
Pivampicillin The therapeutic efficacy of Pivampicillin can be decreased when used in combination with Rolitetracycline.
Pivmecillinam The therapeutic efficacy of Pivmecillinam can be decreased when used in combination with Rolitetracycline.
Ticarcillin The therapeutic efficacy of Ticarcillin can be decreased when used in combination with Rolitetracycline.
Azidocillin The therapeutic efficacy of Azidocillin can be decreased when used in combination with Rolitetracycline.
Carindacillin The therapeutic efficacy of Carindacillin can be decreased when used in combination with Rolitetracycline.
Procaine benzylpenicillin The therapeutic efficacy of Procaine benzylpenicillin can be decreased when used in combination with Rolitetracycline.
Sultamicillin The therapeutic efficacy of Sultamicillin can be decreased when used in combination with Rolitetracycline.
Temocillin The therapeutic efficacy of Temocillin can be decreased when used in combination with Rolitetracycline.
Epicillin The therapeutic efficacy of Epicillin can be decreased when used in combination with Rolitetracycline.
Pheneticillin The therapeutic efficacy of Pheneticillin can be decreased when used in combination with Rolitetracycline.
Carfecillin The therapeutic efficacy of Carfecillin can be decreased when used in combination with Rolitetracycline.
Propicillin The therapeutic efficacy of Propicillin can be decreased when used in combination with Rolitetracycline.
Clometocillin The therapeutic efficacy of Clometocillin can be decreased when used in combination with Rolitetracycline.
Sulbenicillin The therapeutic efficacy of Sulbenicillin can be decreased when used in combination with Rolitetracycline.
Penamecillin The therapeutic efficacy of Penamecillin can be decreased when used in combination with Rolitetracycline.
Talampicillin The therapeutic efficacy of Talampicillin can be decreased when used in combination with Rolitetracycline.
Aspoxicillin The therapeutic efficacy of Aspoxicillin can be decreased when used in combination with Rolitetracycline.
Metampicillin The therapeutic efficacy of Metampicillin can be decreased when used in combination with Rolitetracycline.
Bismuth subcitrate potassium The serum concentration of Rolitetracycline can be decreased when it is combined with Bismuth subcitrate potassium.
Zinc Zinc can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc trihydroxide Zinc trihydroxide can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc Substituted Heme C Zinc Substituted Heme C can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Polaprezinc Polaprezinc can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc oxide Zinc oxide can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc sulfate Zinc sulfate can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc citrate Zinc citrate can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc picolinate Zinc picolinate can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc gluconate Zinc gluconate can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Acetylcysteine zinc Acetylcysteine zinc can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc ascorbate Zinc ascorbate can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc acetate Zinc acetate can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc glycinate Zinc glycinate can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc chloride Zinc chloride can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc sulfate, unspecified form Zinc sulfate, unspecified form can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zinc cation Zinc cation can cause a decrease in the absorption of Rolitetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
BCG vaccine The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Rolitetracycline.
Typhoid vaccine The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Rolitetracycline.
Etonogestrel The serum concentration of Etonogestrel can be decreased when it is combined with Rolitetracycline.
Desogestrel The serum concentration of Desogestrel can be decreased when it is combined with Rolitetracycline.
Megestrol acetate The serum concentration of Megestrol acetate can be decreased when it is combined with Rolitetracycline.
Levonorgestrel The serum concentration of Levonorgestrel can be decreased when it is combined with Rolitetracycline.
Dydrogesterone The serum concentration of Dydrogesterone can be decreased when it is combined with Rolitetracycline.
Progesterone The serum concentration of Progesterone can be decreased when it is combined with Rolitetracycline.
Medroxyprogesterone acetate The serum concentration of Medroxyprogesterone acetate can be decreased when it is combined with Rolitetracycline.
Norethisterone The serum concentration of Norethisterone can be decreased when it is combined with Rolitetracycline.
Ethynodiol diacetate The serum concentration of Ethynodiol diacetate can be decreased when it is combined with Rolitetracycline.
Norgestimate The serum concentration of Norgestimate can be decreased when it is combined with Rolitetracycline.
Drospirenone The serum concentration of Drospirenone can be decreased when it is combined with Rolitetracycline.
Allylestrenol The serum concentration of Allylestrenol can be decreased when it is combined with Rolitetracycline.
Cyproterone acetate The serum concentration of Cyproterone acetate can be decreased when it is combined with Rolitetracycline.
Norelgestromin The serum concentration of Norelgestromin can be decreased when it is combined with Rolitetracycline.
Gestodene The serum concentration of Gestodene can be decreased when it is combined with Rolitetracycline.
Hydroxyprogesterone caproate The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Rolitetracycline.
Dienogest The serum concentration of Dienogest can be decreased when it is combined with Rolitetracycline.
Medrogestone The serum concentration of Medrogestone can be decreased when it is combined with Rolitetracycline.
Norethynodrel The serum concentration of Norethynodrel can be decreased when it is combined with Rolitetracycline.
Norgestrel The serum concentration of Norgestrel can be decreased when it is combined with Rolitetracycline.
Altrenogest The serum concentration of Altrenogest can be decreased when it is combined with Rolitetracycline.
Gestrinone The serum concentration of Gestrinone can be decreased when it is combined with Rolitetracycline.

Target Protein

30S ribosomal protein S9 rpsI
16S ribosomal RNA

Referensi & Sumber

Synthesis reference: Horacio Alfredo Priestap, Carlos Rappaport, "Process for producing rolitetracycline." U.S. Patent US3985768, issued September, 1963.

Contoh Produk & Brand

Produk: 1 • International brands: 2
Produk
  • Reverin 275mg
    Powder, for solution • 275 mg / vial • Intra-articular; Intraperitoneal; Intrapleural; Intrathecal; Intravenous • Canada • Approved
International Brands
  • Reverin
  • Synterin

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul